Alessandro Rambaldi

机构：University of Bergamo, University of Milan, Ospedale Papa Giovanni XXIII, Fondazione Europea Ricerca Biomedica, Ospedale generale di zona San Camillo Treviso · ORCID：0000-0002-3739-7502

发表论文 1467 篇 · 总被引 62107 次 · h-index 128

代表论文

• First results of the Phase III GIMEMA ALL2820 trial comparing ponatinib plus blinatumomab to imatinib and chemotherapy for newly diagnosed adult ph+ acute lymphoblastic leukemia patients (2025 · Blood · 被引 14)
• Non‐T‐Depleted Haploidentical Transplantation Compared to Allogeneic Transplantation From Matched Siblings or Unrelated Donors in Patients With Secondary AML in First Complete Remission: A Study From the ALWP / EBMT (2025 · American Journal of Hematology · 被引 5)
• Venetoclax and decitabine in myeloproliferative neoplasm-blast Phase (MPN-BP): Results of enable, a gimema and airc-mynerva multicenter, Phase 2 trial (2025 · Blood · 被引 5)
• T-cell replete haploidentical transplantation compared to mismatched unrelated allogeneic transplantation with post-transplantation cyclophosphamide in patients with secondary acute myeloid leukemia in first complete remission: A study from the ALWP/EBMT (2026 · PubMed Central · 被引 3)
• Immunomodulatory effect of dasatinib plus blinatumomab versus ponatinib plus blinatumomab in newly diagnosed Ph+ acute lymphoblastic leukemia (2026 · Leukemia · 被引 3)
• Addition of thiotepa to a busulphan based conditioning regimen does not improve survival in patients allografted for acute myeloid leukaemia and myelodysplasia: Results of the UK impact cosi trial (2025 · Blood · 被引 3)